{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:45:50Z","timestamp":1793119550017,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009329","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000}}],"reference-count":111,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009329.pub2","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T10:25:56Z","timestamp":1369736756000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":440,"title":["Pharmacological interventions for smoking cessation: an overview and network meta-analysis"],"prefix":"10.1002","volume":"2015","author":[{"given":"Kate","family":"Cahill","sequence":"first","affiliation":[{"name":"University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stevens","sequence":"additional","affiliation":[{"name":"University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Perera","sequence":"additional","affiliation":[{"name":"University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lancaster","sequence":"additional","affiliation":[{"name":"University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,31]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0001|cit1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub3","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0002|cit2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002849","article-title":"Anxiolytics for smoking cessation","author":"Hughes","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0003|cit3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000058.pub2","article-title":"Clonidine for smoking cessation","author":"Gourlay","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0004|cit4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000124","article-title":"Lobeline for smoking cessation","author":"Stead","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0005|cit5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001009","article-title":"Mecamylamine (a nicotine antagonist) for smoking cessation","author":"Lancaster","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005990","article-title":"Nicobrevin for smoking cessation","author":"Stead","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0007|cit7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006103.pub5","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Cahill","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009329.pub2-BIB0008|cit8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007072","article-title":"Nicotine vaccines for smoking cessation","author":"Hartmann-Boyce","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0009|cit9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub3","article-title":"Nicotine replacement therapy for smoking cessation","author":"Stead","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003086.pub2","article-title":"Opioid antagonists for smoking cessation","author":"David","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005353.pub4","article-title":"Cannabinoid type 1 receptor antagonists for smoking cessation","author":"Cahill","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000191","article-title":"Silver acetate for smoking cessation","author":"Lancaster","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003289","article-title":"Tobacco cessation interventions for young people","author":"Grimshaw","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002999","article-title":"Smoking cessation for chronic obstructive pulmonary disease","author":"Meer","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001837.pub2","article-title":"Interventions for smoking cessation in hospitalised patients","author":"Rigotti","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD009329.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007078.pub3","article-title":"Internet-based interventions for smoking cessation","author":"Civljak","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003698.pub2","article-title":"Community pharmacy personnel interventions for smoking cessation","author":"Sinclair","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009329.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002294.pub3","article-title":"Interventions for preoperative smoking cessation","author":"Thomsen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001055.pub3","article-title":"Interventions for promoting smoking cessation during pregnancy","author":"Lumley","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008033.pub2","article-title":"Reduction versus abrupt cessation in smokers who want to quit","author":"Lindson","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003999.pub3","article-title":"Relapse prevention interventions for smoking cessation","author":"Hajek","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009329.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007253.pub2","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia","author":"Tsoi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006219.pub2","article-title":"Interventions for preventing weight gain after smoking cessation","author":"Parsons","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003440.pub3","article-title":"Workplace interventions for smoking cessation","author":"Cahill","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7454","key":"10.1002\/14651858.CD009329.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/clpt.2008.3","article-title":"Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction","volume":"83","author":"Benowitz","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2165\/00002018-200831110-00006","article-title":"Serious Adverse Reactions of Bupropion for Smoking Cessation Analysis of the French Pharmacovigilance Database from 2001 to 2004","volume":"31","author":"Beyens","year":"2008","journal-title":"Drug Safety"},{"issue":"10","key":"10.1002\/14651858.CD009329.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00228-003-0693-0","article-title":"Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000","volume":"59","author":"Boshier","year":"2003","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General methods for monitoring convergence of iterative simulations","volume":"7","author":"Brooks","year":"1998","journal-title":"Journal of Computational and Graphical Statistics"},{"issue":"6","key":"10.1002\/14651858.CD009329.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study","volume":"192","author":"Chun-Fai-Chan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1002\/14651858.CD009329.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010078","article-title":"Pharmacological interventions for promoting smoking cessation during pregnancy","author":"Coleman","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009329.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0034|cit34","unstructured":"Disease Control Priorities Project Tobacco Addiction http:\/\/www.dcp2.org\/file\/52\/DCPP-Tobacco.pdf (accessed 24th March 2013)"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4088\/JCP.v59n0705","article-title":"A prospective safety surveillance study for bupropion sustained-release in the treatment of depression","volume":"59","author":"Dunner","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004306.pub4","article-title":"Interventions for smokeless tobacco use cessation","author":"Ebbert","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cmaj.070256","article-title":"Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials","volume":"179","author":"Eisenberg","year":"2008","journal-title":"Canadian Medical Association Journal"},{"issue":"8","key":"10.1002\/14651858.CD009329.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1503\/cmaj.081467","article-title":"Correction","volume":"179","author":"Eisenberg","year":"2008","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0039|cit39","unstructured":"Filion K Eisenberg M Personal communication"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0040|cit40","unstructured":"European Agency for the Evaluation of Medicines for Human Use Committee for Proprietary Medicinal Products. Opinion following an article 36 referral. Bupropion hydrochloride http:\/\/www.emea.eu.int\/pdfs\/human\/referral\/2761002en.pdf"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1360-0443.2007.01822.x","article-title":"The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis","volume":"102","author":"Etter","year":"2007","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007650","article-title":"Interventions for neovascular age-related macular degeneration","author":"Evans","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0043|cit43","unstructured":"U. S. Food Drug Administration FDA drug safety communication: safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm276737.htm (accessed 19\/1\/2012) October 2011"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1001\/jama.1992.03490190087036","article-title":"Tobacco dependence and the nicotine patch. Clinical guidelines for effective use","volume":"268","author":"Fiore","year":"1992","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0045|cit45","article-title":"Treating tobacco use and dependence: 2008 update","volume-title":"Treating tobacco use and dependence: 2008 Update. Clinical Practice Guideline","author":"Fiore","year":"2008"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0046|cit46","unstructured":"GlaxoSmithKline Zyban(R) bupropion hydrochloride Sustained-Release Tablets. Product Information www.gsk.com\/products\/assets\/us_zyban.pdf"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0047|cit47","volume-title":"Smoking and drinking among adults, 2009. A report on the 2009 General Lifestyle Survey","author":"Office for National Statistics","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an \u03b14\u00df2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00002018-199818040-00005","article-title":"A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch","volume":"18","author":"Greenland","year":"1998","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"b3805","DOI":"10.1136\/bmj.b3805","article-title":"Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database","volume":"339","author":"Gunnell","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0051|cit51","unstructured":"Hajek P McRobbie H Myers K Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis Thorax 10.1136\/thoraxjnl-2012-203035"},{"issue":"9","key":"10.1002\/14651858.CD009329.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/11594450-000000000-00000","article-title":"Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand","volume":"34","author":"Harrison-Woolrych","year":"2011","journal-title":"Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/11597690-000000000-00000","article-title":"Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand","volume":"35","author":"Harrison-Woolrych","year":"2012","journal-title":"Drug Safety"},{"issue":"10","key":"10.1002\/14651858.CD009329.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/thx.2005.041798","article-title":"Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network","volume":"60","author":"Hubbard","year":"2005","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/1462220031000070552","article-title":"Measures of abstinence in clinical trials: issues and recommendations","volume":"5","author":"Hughes","year":"2003","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an \u03b14\u00df2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM199612123352402","article-title":"The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease","volume":"335","author":"Joseph","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/pcad.2003.YPCAD14","article-title":"Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease","volume":"45","author":"Joseph","year":"2003","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009329.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00002018-200932060-00006","article-title":"Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study","volume":"32","author":"Kasliwal","year":"2009","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.jcp.0000162805.46453.e3","article-title":"Inhibition of CYP2D6 activity by bupropion","volume":"25","author":"Kotlyar","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD009329.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archinternmed.2010.33","article-title":"Bupropion and cognitive behavioural therapy for weight-concerned women smokers","volume":"170","author":"Levine","year":"2010","journal-title":"Archives of Internal Medicine"},{"issue":"20","key":"10.1002\/14651858.CD009329.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"474","key":"10.1002\/14651858.CD009329.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001055.pub3","article-title":"Interventions for promoting smoking cessation during pregnancy","author":"Lumley","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0065|cit65","unstructured":"Mallett S Hopewell S Clarke M Grey literature in systematic reviews: The first 1000 Cochrane systematic reviews Fourth symposium on systematic reviews: Pushing the boundaries Oxford 2002"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.amjcard.2004.12.039","article-title":"Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes","volume":"95","author":"Meine","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1360-0443.2012.04024.x","article-title":"Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System","volume":"108","author":"Meyer","year":"2013","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0068|cit68","unstructured":"Pharmacovigilance Information Unit Medicines and Healthcare products Regulatory Agency (UK) Personal Communication"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0069|cit69","unstructured":"Medicines and Healthcare products Regulatory Agency MHRA UK Public Assessment Report|: Nicobrevin: withdrawn from UK market as risks outweigh benefits http:\/\/www.mhra.gov.uk\/home\/groups\/pl-p\/documents\/websiteresources\/con114612.pdf (accessed 20\/11\/2012) April 2011"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1617-9625-8-8","article-title":"Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals","volume":"8","author":"Mills","year":"2010","journal-title":"Tobacco Induced Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009329.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/07853890.2012.705016","article-title":"Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis","volume":"44","author":"Mills","year":"2012","journal-title":"Annals of Medicine"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0072|cit72","unstructured":"Centers for Disease Control and Prevention Cigarette smoking-attributable morbidity - United States 2000 MMWR Sep 2003"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0073|cit73","first-page":"1157","article-title":"Cigarette smoking among adults-United States, 2006","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR"},{"issue":"9","key":"10.1002\/14651858.CD009329.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1471-0528.2012.03408.x","article-title":"Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis","volume":"119","author":"Myung","year":"2012","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0075|cit75","volume-title":"Statistics on smoking: England","author":"The Information Centre for Health and Social Care","year":"2008"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2165\/00003495-199244030-00011","article-title":"Transdermal Nicotine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation","volume":"44","author":"Palmer","year":"1992","journal-title":"Drugs"},{"issue":"12","key":"10.1002\/14651858.CD009329.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archinternmed.2011.72","article-title":"Bupropion for smoking cessation in patients with acute coronary syndrome","volume":"171","author":"Planer","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0078|cit78","unstructured":"Plummer M JAGS: a program for analysis of bayesian graphical models using gibbs sampling 2003"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0079|cit79","unstructured":"Plummer M RJAGS: Bayesian graphical models using MCMC (http:\/\/CRAN.R-project.org\/package=rjags) 2012"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.amepre.2007.05.006","article-title":"Nicotine replacement and behavioral therapy for smoking cessation in pregnancy","volume":"33","author":"Pollak","year":"2007","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e2856","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0082|cit82","unstructured":"Royal College of Physicians Tobacco Addiction in Britain: a report of the Tobacco Advisory Group of the Royal College of Physicians http:\/\/old.rcplondon.ac.uk\/pubs\/books\/nicotine\/index.htm (accessed 19th April 2011) 2000"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000005.pub3","article-title":"Full publication of results initially presented in abstracts","author":"Scherer","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0085|cit85","unstructured":"Department of Health Report of the Scientific Committee on Tobacco and Health http:\/\/www.archive.official-documents.co.uk\/document\/doh\/tobacco\/report.htm (accessed 19th April 2011) 1998"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0087|cit87","unstructured":"Shea B Personal communication August 2011"},{"issue":"12","key":"10.1002\/14651858.CD009329.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1503\/cmaj.110218","article-title":"Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis","volume":"183","author":"Singh","year":"2011","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/1467-9868.00353","article-title":"Bayesian measures of model complexity and fit","volume":"64","author":"Spiegelhalter","year":"2002","journal-title":"Journal of the Royal Statistical Society: Series B: Statistical Methodlogy"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14622200210123581","article-title":"Biochemical verification of tobacco use and cessation","volume":"4","author":"SRNT Subcommittee on Biochemical Verification","year":"2002","journal-title":"Nicotine & Tobacco Research"},{"issue":"2","key":"10.1002\/14651858.CD009329.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/096228029800700206","article-title":"Cigarette smoking prevalence, cessation and relapse","volume":"7","author":"Stapleton","year":"1998","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0092|cit92","unstructured":"Team RC A language and environment for statistical computing http:\/\/www.R-project.org (accessed 20\/11\/2012) 2012"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0093|cit93","unstructured":"Adverse Drugs Reactions Unit Therapeutic Goods Administration (Australia) Personal Communication"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0094|cit94","unstructured":"Thorlund K Thabane L Mills EJ Modelling heterogeneity variances in multiple treatment comparison meta-analysis - Are informative priors the better solution? Medical Research Methodology 10.1186\/1471-2288-13-2"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.1994.00420090063007","article-title":"Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease","volume":"154","author":"Transdermal Nicotine Working Group","year":"1994","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0096|cit96","article-title":"The Tobacco Atlas","volume-title":"The Tobacco Atlas","author":"Shafey","year":"2010"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/11319180-000000000-00000","article-title":"Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis","volume":"33","author":"Tonstad","year":"2010","journal-title":"Drug Safety"},{"issue":"6","key":"10.1002\/14651858.CD009329.pub2-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007253.pub2","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia","author":"Tsoi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009329.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1183\/09031936.00155811","article-title":"Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double blind trial","volume":"40","author":"T\u00f8nnesen","year":"2012","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0100|cit100","unstructured":"Current Controlled Trials metaRegister of Controlled Trials (mRCT)"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0101|cit101","unstructured":"United States National Institutes of Health ClinicalTrials.gov"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0102|cit102","first-page":"1","article-title":"Varenicline and bupropion. Reports of suicidality associated with used of varenicline (marketed as CHANTIX) and bupropion (marketed as Zyban and generics)","volume":"2","author":"Anon","year":"2009","journal-title":"FDA Drug Safety Newsletter"},{"issue":"1","key":"10.1002\/14651858.CD009329.pub2-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006102","article-title":"Smoking cessation interventions for smokers with current or past depression","author":"Meer","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0104|cit104","doi-asserted-by":"crossref","unstructured":"van Valkenhoef G Lu G de Brock B Hillege H Ades AE Welton NJ Automating network meta-analysis Research Synthesis Methods 2012 10.1002\/jrsm.1054","DOI":"10.1002\/jrsm.1054"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0105|cit105","unstructured":"van Valkenhoef G Kuiper J GeMTC: GeMTC network meta-analysis http:\/\/CRAN.R-project.org\/package=gemtc (accessed 20\/11\/2012) 2012"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1360-0443.1999.94341711.x","article-title":"The long-term effect of nicotine on the oral mucosa","volume":"94","author":"Wallstrom","year":"1999","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0107|cit107","unstructured":"West R Background smoking cessation rates in England http:\/\/www.smokinginengland.info\/Ref\/paper2.pdf (accessed 19th April 2011) 2006"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0108|cit108","unstructured":"World Health Organization 17th expert committee on the selection and use of essential medicines http:\/\/www.who.int\/selection_medicines\/committees\/expert\/17\/en\/index.html (accessed 19th April 2011) 2009"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0109|cit109","unstructured":"World Health Organization Internation Clinical Trials Registry Platform Search Portal"},{"issue":"4","key":"10.1002\/14651858.CD009329.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1185\/030079907X182185","article-title":"A double-blind study evaluating the long-term safety of varenicline for smoking cessation","volume":"23","author":"Williams","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD009329.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/1471-2458-6-300","article-title":"Effectiveness of smoking cessation therapies: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2006","journal-title":"BMC Public Health"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009329.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T04:02:32Z","timestamp":1715400152000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009329.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Tobacco Addiction Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,31]]},"references-count":111,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009329.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718016272.793480742","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,31]]}}}